The shares of Symbiotec Pharmalab IPO are commanding a strong premium of ₹270 in the grey market. The GMP of Symbiotec Pharmalab IPO is +270, according to Investorgain.
Source :- mint – markets Read More
The shares of Symbiotec Pharmalab IPO are commanding a strong premium of ₹270 in the grey market. The GMP of Symbiotec Pharmalab IPO is +270, according to Investorgain.